VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
UHSUniversal Health Services, Inc.
$141.17$8.8B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. UHS
  3. Financial Ratios

Universal Health Services, Inc. (UHS) Financial Ratios

30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities

View Quarterly Ratios →

P/E Ratio
↓
6.11
↓-50% vs avg
5yr avg: 12.28
00%ile100
30Y Low9.4·High37.3
View P/E History →
EV/EBITDA
↓
5.44
↓-35% vs avg
5yr avg: 8.39
07%ile100
30Y Low4.4·High13.4
P/FCF
↓
10.40
↓-89% vs avg
5yr avg: 94.90
09%ile100
30Y Low7.2·High111.5
P/B Ratio
↑
1.23
↓-31% vs avg
5yr avg: 1.78
03%ile100
30Y Low1.1·High4.3
ROE
↑
21.0%
↓+36% vs avg
5yr avg: 15.5%
0100%ile100
30Y Low10%·High21%
Debt/EBITDA
↓
2.11
↓-20% vs avg
5yr avg: 2.62
053%ile100
30Y Low0.9·High5.4

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

UHS Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Universal Health Services, Inc. trades at 6.1x earnings, 50% below its 5-year average of 12.3x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 72%. On a free-cash-flow basis, the stock trades at 10.4x P/FCF, 89% below the 5-year average of 94.9x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$8.8B$14.1B$12.2B$10.7B$10.4B$10.9B$11.8B$12.8B$10.9B$10.9B$10.5B
Enterprise Value$14.2B$19.4B$17.0B$15.9B$15.6B$15.3B$14.7B$17.0B$14.8B$14.9B$14.6B
P/E Ratio →6.119.4410.6714.9015.4110.9712.5115.7114.0114.5114.90
P/S Ratio0.510.810.770.750.780.861.021.121.011.051.07
P/B Ratio1.231.901.801.721.741.751.842.292.002.162.27
P/FCF10.4016.5510.8420.3739.70387.067.2416.4820.6519.0578.54
P/OCF4.747.545.898.4310.4412.284.998.888.159.238.12

P/E links to full P/E history page with 30-year chart

UHS EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Universal Health Services, Inc.'s enterprise value stands at 5.4x EBITDA, 35% below its 5-year average of 8.4x. The Healthcare sector median is 14.2x, placing the stock at a 62% discount on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—1.121.071.121.161.211.281.501.381.431.49
EV / EBITDA5.447.437.519.149.828.077.899.989.108.618.58
EV / EBIT7.129.1410.1213.8915.6811.1110.8513.8512.5411.7311.52
EV / FCF—22.8715.1430.3759.42545.579.0621.9728.0025.97109.32

UHS Profitability

Margins and return-on-capital ratios measuring operating efficiency

Universal Health Services, Inc. earns an operating margin of 11.5%. Operating margins have expanded from 8.2% to 11.5% over the past 3 years, signaling improving operational efficiency. ROE of 21.0% indicates solid capital efficiency. ROIC of 12.3% represents solid returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin90.4%90.4%90.0%89.3%89.0%88.7%88.9%89.0%89.2%89.4%89.4%
Operating Margin11.5%11.5%10.6%8.2%7.5%10.8%11.8%10.7%10.9%12.3%13.1%
Net Profit Margin8.6%8.6%7.2%5.0%5.0%7.8%8.2%7.2%7.2%7.2%7.2%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE21.0%21.0%17.6%11.8%11.1%15.7%15.7%14.7%14.8%15.6%15.3%
ROA9.8%9.8%8.0%5.2%5.1%7.5%7.5%7.1%7.1%7.1%7.0%
ROIC12.3%12.3%10.9%7.8%6.9%10.2%10.6%9.5%9.6%10.8%11.6%
ROCE16.0%16.0%13.9%10.0%8.8%12.3%12.9%12.2%12.5%14.3%14.6%

UHS Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Universal Health Services, Inc. carries a Debt/EBITDA ratio of 2.1x, which is manageable (34% below the sector average of 3.2x). Net debt stands at $5.4B ($5.5B total debt minus $138M cash). Interest coverage of 13.5x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.740.740.730.870.880.740.650.770.730.800.90
Debt / EBITDA2.112.112.193.083.322.402.242.532.462.342.44
Net Debt / Equity—0.720.710.850.870.720.460.760.710.780.89
Net Debt / EBITDA2.062.062.133.013.262.341.592.492.392.292.42
Debt / FCF—6.324.3010.0019.73158.511.835.487.366.9230.79
Interest Coverage13.5113.518.965.537.8016.1512.457.557.638.8810.84

UHS Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

A current ratio of 1.05x means Universal Health Services, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.40x to 1.05x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.051.051.271.401.331.141.321.231.340.971.28
Quick Ratio0.980.981.171.291.211.041.251.121.240.901.18
Cash Ratio0.040.040.060.060.050.060.490.040.070.040.03
Asset Turnover—1.091.091.020.990.970.860.980.960.970.95
Inventory Turnover7.157.157.197.066.756.906.767.837.898.128.23
Days Sales Outstanding—54.7050.2257.2054.9650.4354.6050.0751.1652.6353.80

UHS Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Universal Health Services, Inc. returns 11.5% to shareholders annually — split between a 0.6% dividend yield and 11.0% buyback yield. The payout ratio of 3.4% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 16.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield0.6%0.4%0.4%0.5%0.6%0.6%0.1%0.4%0.3%0.4%0.4%
Payout Ratio3.4%3.4%4.7%7.7%8.7%6.6%1.8%6.5%4.8%5.1%5.5%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield16.4%10.6%9.4%6.7%6.5%9.1%8.0%6.4%7.1%6.9%6.7%
FCF Yield9.6%6.0%9.2%4.9%2.5%0.3%13.8%6.1%4.8%5.2%1.3%
Buyback Yield11.0%6.9%5.5%5.1%8.0%11.3%1.8%6.0%3.6%3.3%3.4%
Total Shareholder Yield11.5%7.3%5.9%5.6%8.6%11.9%1.9%6.4%4.0%3.7%3.7%
Shares Outstanding—$64M$68M$70M$74M$84M$86M$89M$94M$96M$98M

Peer Comparison

Compare UHS with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
UHS logoUHSYou$9B6.15.410.490.4%11.5%21.0%12.3%2.1
HCA logoHCA$84B13.28.610.941.5%15.8%—19.9%3.2
THC logoTHC$15B11.15.96.082.3%16.1%16.1%13.2%3.1
CYH logoCYH$426M0.8—2.08.7%-79.4%—-70.1%—
ENSG logoENSG$9B26.323.524.213.7%8.6%16.9%7.0%7.7
ACHC logoACHC$2B-2.08.3—17.6%11.7%-41.4%5.9%4.6
SEM logoSEM$2B14.012.15.411.5%6.1%7.3%4.8%7.8
SGRY logoSGRY$2B-23.910.19.723.1%11.8%-2.2%4.1%7.1
USPH logoUSPH$964M44.613.215.820.1%10.3%2.0%5.6%4.1
PRAA logoPRAA$570M-1.91.2—99.2%33.9%-27.3%11.2%0.1
UNH logoUNH$364B30.317.922.618.5%4.2%11.8%9.2%3.4
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

UHS — Frequently Asked Questions

Quick answers to the most common questions about buying UHS stock.

What is Universal Health Services, Inc.'s P/E ratio?

Universal Health Services, Inc.'s current P/E ratio is 6.1x. The historical average is 16.0x.

What is Universal Health Services, Inc.'s EV/EBITDA?

Universal Health Services, Inc.'s current EV/EBITDA is 5.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.1x.

What is Universal Health Services, Inc.'s ROE?

Universal Health Services, Inc.'s return on equity (ROE) is 21.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 14.5%.

Is UHS stock overvalued?

Based on historical data, Universal Health Services, Inc. is trading at a P/E of 6.1x. Compare with industry peers and growth rates for a complete picture.

What is Universal Health Services, Inc.'s dividend yield?

Universal Health Services, Inc.'s current dividend yield is 0.56% with a payout ratio of 3.4%.

What are Universal Health Services, Inc.'s profit margins?

Universal Health Services, Inc. has 90.4% gross margin and 11.5% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Universal Health Services, Inc. have?

Universal Health Services, Inc.'s Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.